Piracetam
What it is
The original racetam nootropic, synthesised in 1964 by Corneliu Giurgea who coined the term "nootropic." Modulates AMPA and NMDA receptors and improves membrane fluidity. Cochrane review found insufficient evidence for cognitive enhancement in healthy adults but modest benefits in age-related cognitive decline. Approved as a prescription drug in many European countries. Very safe profile.
Dose
1,200–4,800 mg/day in 2–3 divided doses; higher doses often needed for noticeable effects
Time of day & tips
High doses are needed — many users report nothing below 2,400 mg/day. Pair with a choline source to prevent headaches. Prescription drug in Europe, unregulated in the US. Very safe even at high doses.
Compare or learn more
Compare with another supplement →
Browse by symptom →
Open the full interactive view →